关注
Eileen M. O'Reilly
Eileen M. O'Reilly
在 mskcc.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
T Golan, P Hammel, M Reni, E Van Cutsem, T Macarulla, MJ Hall, ...
New England Journal of Medicine 381 (4), 317-327, 2019
20012019
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303)
HL Kindler, D Niedzwiecki, D Hollis, S Sutherland, D Schrag, H Hurwitz, ...
Journal of Clinical Oncology 28 (22), 3617-3622, 2010
9912010
Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology
MA Tempero, MP Malafa, M Al-Hawary, H Asbun, A Bain, SW Behrman, ...
Journal of the National Comprehensive Cancer Network 15 (8), 1028-1061, 2017
9822017
Pancreatic cancer: a review
W Park, A Chawla, EM O’Reilly
Jama 326 (9), 851-862, 2021
9492021
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection
I Endo, M Gonen, AC Yopp, KM Dalal, Q Zhou, D Klimstra, M D'Angelica, ...
Annals of surgery 248 (1), 84-96, 2008
9262008
Extracellular vesicle and particle biomarkers define multiple human cancers
A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ...
Cell 182 (4), 1044-1061. e18, 2020
8692020
Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a …
AP Venook, D Niedzwiecki, HJ Lenz, F Innocenti, B Fruth, JA Meyerhardt, ...
Jama 317 (23), 2392-2401, 2017
8382017
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group–directed intergroup trial …
PA Philip, J Benedetti, CL Corless, R Wong, EM O'Reilly, PJ Flynn, ...
Journal of clinical oncology 28 (22), 3605-3610, 2010
7372010
Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer
AA Khorana, GA Soff, AK Kakkar, S Vadhan-Raj, H Riess, T Wun, ...
New England Journal of Medicine 380 (8), 720-728, 2019
6752019
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma
MA Shah, RK Ramanathan, DH Ilson, A Levnor, D D'Adamo, E O'Reilly, ...
Journal of Clinical Oncology 24 (33), 5201-5206, 2006
5792006
Gallbladder cancer (GBC): 10‐year experience at memorial Sloan‐Kettering cancer centre (MSKCC)
A Duffy, M Capanu, GK Abou‐Alfa, D Huitzil, W Jarnagin, Y Fong, ...
Journal of surgical oncology 98 (7), 485-489, 2008
5512008
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
F Fata, E O'Reilly, D Ilson, D Pfister, D Leffel, DP Kelsen, GK Schwartz, ...
Cancer 86 (10), 2034-2037, 1999
5361999
Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, ...
Journal of clinical oncology 37 (4), 286-295, 2019
5182019
Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial
EM O’Reilly, DY Oh, N Dhani, DJ Renouf, MA Lee, W Sun, G Fisher, ...
JAMA oncology 5 (10), 1431-1438, 2019
5142019
Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
JM Herman, DT Chang, KA Goodman, AS Dholakia, SP Raman, ...
Cancer 121 (7), 1128-1137, 2015
5102015
Impact of primary (1º) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB …
AP Venook, D Niedzwiecki, F Innocenti, B Fruth, C Greene, BH O'Neil, ...
Journal of Clinical Oncology 34 (15_suppl), 3504-3504, 2016
4932016
Intrahepatic cholangiocarcinoma: expert consensus statement
SM Weber, D Ribero, EM O'Reilly, N Kokudo, M Miyazaki, TM Pawlik
Hpb 17 (8), 669-680, 2015
4682015
Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, ...
Jama 318 (9), 825-835, 2017
4622017
Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention
MA Lowery, R Ptashkin, E Jordan, MF Berger, A Zehir, M Capanu, ...
Clinical Cancer Research 24 (17), 4154-4161, 2018
4352018
NCCN guidelines insights: pancreatic adenocarcinoma, version 1.2019: featured updates to the NCCN guidelines
MA Tempero, MP Malafa, EG Chiorean, B Czito, C Scaife, AK Narang, ...
Journal of the National Comprehensive Cancer Network 17 (3), 202-210, 2019
3852019
系统目前无法执行此操作,请稍后再试。
文章 1–20